Fabry Disease

Cannabis Triumphs Where Pain Meds Failed: A Case Study In Fabry Disease

4D Molecular Shares Updated Data From Fabry Disease Trial

After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data

4D Molecular Shares Updated Data From Fabry Disease Trial

After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data

Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial

Why Avrobio's Shares Are Plunging Today

Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial

Why Avrobio's Shares Are Plunging Today

Freeline Therapeutics Touts Encouraging Data From Fabry Disease Program

Why Did Sangamo Stock Jump 20% Today?

Fabry Disease Recent News

4D Molecular's Fabry Disease Candidate Shows Early Proof-Of-Concept

Amicus's Fabry Disease Medicine Gets European Approval For Use In Adolescents

Protalix Stock Is Trading Higher On Meeting Request To FDA For Fabry Disease Candidate Application

Protalix Shares Hits 52-Week Low After Adverse Event Reported In Fabry Disease Trial With PRX-102

Avrobio Plans Registration Trial With Kidney Biopsy Endpoint To Support Potential Full Approval Of Fabry Disease Gene Therapy

Protalix Stock Falls After FDA Slaps CRL For PRX-102 Application In Fabry Disease

Sigilon Therapeutics' Fabry Disease Therapy Receives Orphan Drug Designation In US

Protalix's PRX–102 Monthly Treatment Shows Benefit In Fabry Disease

Avrobio Shares Rally On Fabry Disease Gene Therapy Encouraging Benefit In Early-Stage Study

Amicus Therapeutics Building Rare Disease Treatment Strategy; Bank Of America Initiates At Buy

Amicus Therapeutics Gains 3% On Favorable EU Medicines Recommendation